πŸ‡ΊπŸ‡Έ FDA
Patent

US 9108970

Fused heteroaromatic pyrrolidinones

granted A61KA61K31/437A61K31/519

Quick answer

US patent 9108970 (Fused heteroaromatic pyrrolidinones) held by Takeda Pharmaceutical Company Limited expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/437, A61K31/519, A61K31/527, A61K45/06